Positron emission tomography scanning in essential blepharospasm

American Journal of Ophthalmology

Volumn 136, Issue 5, 2003, Pages 846-852

  Kerrison, John B ^a,d   Lancaster, Jack L ^b   Zamarripa, Frank E ^b   Richardson, Londe A ^a   Morrison, John C ^a   Holck, David E E ^a   Andreason, Kurt W ^a   Blaydon, Sean M ^c   Fox, Peter T ^b  

^a WILFORD HALL MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c BROOKE ARMY MEDICAL CENTER   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BLEPHAROSPASM; BRAIN CORTEX; CAUDATE NUCLEUS; CEREBELLUM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FRONTAL CORTEX; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; THALAMUS;

EID: 0142257971     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(03)00895-X     Document Type: Article

References (46)

1. A prevalence study of primary dystonia in eight European countries. J Neurol. 247:2000;787-792.
2. Defazio G., Livrea P., De Salvia R., et al. Prevalence of primary blepharospasm in a community of Puglia region, Southern Italy. Neurology. 56:2001;1579-1581.
3. Castelbuono A., Miller N.R. Spontaneous remission in patients with essential blepharospasm and Meige syndrome. Am J Ophthalmol. 126:1998;432-435.
4. Mezaki T., Kaji R., Brin M.F., et al. Combined use of type A and F botulinum toxins for blepharospasm a double-blind controlled trial . Mov Disord. 14:1999;1017-1020.
5. Frueh B.R., Felt D.P., Wojno T.H., Musch D.C. Treatment of blepharospasm with botulinum toxin. A preliminary report. Arch Ophthalmol. 102:1984;1464-1468.
6. Scott A.B., Kennedy R.A., Stubbs H.A. Botulinum A toxin injection as a treatment for blepharospasm. Arch Ophthalmol. 103:1985;347-350.
7. Tucha O., Naumann M., Berg D., Alders G.L., Lange K.W. Quality of life in patients with blepharospasm. Acta Neurol Scand. 103:2001;49-52.
8. Wirtschafter J.D., McLoon L.K. Long-term efficacy of local doxorubicin chemomyectomy in patients with blepharospasm and hemifacial spasm. Ophthalmology. 105:1998;342-346.
9. Chapman K.L., Bartley G.B., Waller R.R., Hodge D.O. Follow-up of patients with essential blepharospasm who underwent eyelid protractor myectomy at the Mayo Clinic from 1980 through 1995. Ophthal Plast Reconstr Surg. 15:1999;106-110.
10. Roggenkamper P., Nussgens Z. Frontalis suspension for essential blepharospasm unresponsive to botulinum toxin therapy. First results. Ger J Ophthalmol. 2:1993;426-428.
11. Ohara S., Tsuyuzaki J., Hayashi R. Mexiletine in the treatment of blepharospasm experience with the first three patients . Mov Disord. 14:1999;173-175.
12. Verghese J., Milling C., Rosenbaum D.M. Ptosis, blepharospasm, and apraxia of eyelid opening secondary to putaminal hemorrhage. Neurology. 53:1999;652.
13. Miranda M., Millar A. Blepharospasm associated with bilateral infarcts confined to the thalamus case report . Mov Disord. 13:1998;616-617.
14. Kulisevsky J., Avila A., Roig C., Escartin A. Unilateral blepharospasm stemming from a thalamomesencephalic lesion. Mov Disord. 8:1993;239-240.
15. Yin Foo L.G., Scott G., Blumbergs P.C., Patrick B.B., Lionel C.J. Ganglioglioma of the lateral ventricle presenting with blepharospasm - case report and review of the literature. J Clin Neurosci. 8:2001;279-282.
16. Aramideh M., Ongerboer der Visser B.W., Holstege G., Majoie C.B., Speelman J.D. Blepharospasm in association with a lower pontine lesion. Neurology. 46:1996;476-478.
17. Kostic V.S., Stojanovic-Svetel M., Kacar A. Symptomatic dystonias associated with structural brain lesions report of 16 cases . Can J Neurol Sci. 23:1996;53-56.
18. Wali G.M. Asymmetrical blepharospasm associated with a left frontal cortical infarct. Mov Disord. 16:2001;181-182.
19. Hallet M. Blepharospasm recent advances . Neurology. 59:2002;1306-1312.
20. Misbahuddin A., Placzek M.R., Chaudhuri K.R., Wood N.W., Bhatia K.P., Warner T.T. A polymorphism in the dopamine receptor DRD5 is associated with blepharospasm. Neurology. 58:2002;124-126.
21. Schicatano E.J., Basso M.A., Evinger C. Animal model explains the origins of the cranial dystonia benign essential blepharospasm. J Neurophysiol. 77:1997;2842-2846.
22. Gibb W.R., Lees A.J., Marsden C.D. Pathological report of four patients presenting with cranial dystonias. Mov Disord. 3:1988;211-221.
23. Federico F., Simone I.L., Lucivero V., et al. Proton magnetic resonance spectroscopy in primary blepharospasm. Neurology. 51:1998;892-895.
24. Hutchinson M., Nakamura T., Moeller J.R., et al. The metabolic topography of essential blepharospasm a focal dystonia with general implications . Neurology. 55:2000;673-677.
25. Esmaeli-Gutstein B., Nahmias C., Thompson M., Kazdan M., Harvey J. Positron emission tomography in patients with benign essential blepharospasm. Ophthal Plast Reconstr Surg. 15:1999;23-27.
26. Hallett M., Daroff R.B. Blepharospasm report of a workshop . Neurology. 46:1996;1213-1218.
27. Metter E.J., Riege W.H., Kuhl D.E., Phelps M.E. Cerebral metabolic relationships for selected brain regions in healthy adults. J Cereb Blood Flow Metab. 4:1984;1-7.
28. Tyler J.L., Strother S.C., Zatorre R.J., et al. Stability of regional cerebral glucose metabolism in the normal brain measured by positron emission tomography. J Nucl Med. 29:1988;631-642.
29. Fox P.T., Raichle M.E., Mintun M.A., Dence C. Nonoxidative glucose consumption during focal physiologic neural activity. Science. 241:1988;462-464.
30. Friston K.J., Frith C.D., Liddle P.F., Dolan R.J., Lammertsma A.A., Frackowiak R.S. . The relationship between global and local changes in PET scans. J Cereb Blood Flow Metab. 10:1990;458-466.
31. Talairach J, Tournoux P. Co-planar stereotaxic atlas of the human brain. New York: Thieme Medical Publishers, 1988.
32. Lancaster J.L., Fox P.T., Downs H., et al. Global spatial normalization of human brain using convex hulls. J Nucl Med. 40:1999;942-955.
33. Xiong J., Gao J.-H., Lancaster J.L., Fox P.T. Clustered pixels analysis for functional MRI activation studies of the human brain. Human Brain Mapping. 3:1995;287-301.
34. Poline J.-B., Mazoyer B.M. Analysis of individual positron emission tomography activation maps by detection of high signal-to-noise-ratio pixel clusters. J Cereb Blood Flow Metab. 13:1993;425-437.
35. Roland P.E., Levin B., Kawashima R., Akerman S. Three-dimensional analysis of clustered voxels in 15O-butanol brain activation images. Human Brain Mapping. 1:1993;3-9.
36. Mintun M.A., Fox P.T., Raichle M.E. A highly accurate method of localizing regions of neuronal activation in the human brain with positron emission tomography. J Cereb Blood Flow Metab. 9:1989;96-103.
37. Aramideh M., Ongerboer de Visser B.W., Devriese P.P., Bour L.J., Speelman J.D. Electromyographic features of levator palpebrae superioris and orbicularis oculi muscles in blepharospasm. Brain. 117:1994;27-38.
38. Berardelli A., Rothwell J.C., Hallett M., Thompson P.D., Manfredi M., Marsden C.D. The pathophysiology of primary dystonia. Brain. 121:1998;1195-1212.
39. Berardelli A., Rothwell J.C., Day B.L., Marsden C.D. Pathophysiology of blepharospasm and oromandibular dystonia. Brain. 108:1985;593-608.
40. Namerow N.S. The orbicularis oculi reflex in multiple sclerosis. Neurology. 20:1970;1200-1203.
41. Chia L.-G. Late blink reflex changes in lesions of the thalamus and internal capsule. Neurology. 49:1997;874-876.
42. Blaxton T.A., Zeffiro T.A., Gabrieli J.D.E., et al. Functional mapping of human learning A positron tomography activation study of eyeblink conditioning . J Neurosci. 16:1996;4032-4040.
43. Tsubota K., Kwong K.K., Tsung-Yi L., Nakamura J., Cheng H.-M. Functional MRI of brain activation by eye blinking. Exp Eye Res. 69:1999;1-7.
44. Sibony P.A., Evinger C. Anatomy and physiology of normal and abnomal eyelid position and movement. Miller N.R., Newman N.J. Walsh & Hoyt's clinical neuro-ophthalmology, 6th edition. 1997;1509-1592 Williams & Wilkens, Baltimore.
45. Taylor J.R., Elsworth J.D., Lawrence M.S., Sladek J.R. Jr, Roth R.H., Redmond D.E. Jr. Spontaneous blink rates correlate with dopamine levels in the caudate nucleus of MPTP-treated monkeys. Exp Neurol. 158:1999;214-220.
46. Krupa DJ, Thompson RF. Inactivation of the superior cerebellar peduncle blocks expression but not acquisition of the rabbit's classically conditioned eye-blink response. Proc Natl Acad Sci U S A 1995;5097-5101.